LIGAND PHARMACEUTICALS (LGND) Stock Cash Flow
NASDAQ:LGND • US53220K5048
Current stock price
231.82 USD
+8.58 (+3.84%)
At close:
231.733 USD
-0.09 (-0.04%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 124.45M | -4.03M | 52.15M | -33.40M | 57.10M | |||
| Depreciation Amortization | 33.77M | 35.24M | 36.52M | 51.50M | 51.10M | |||
| Income Taxes - Deferred | 22.68M | -15.80M | 11.70M | 20.70M | -8.60M | |||
| Change In Working Capital | -12.66M | 19.36M | -34.40M | 65.70M | -52.20M | |||
| Interest Paid | 321.00K | 263.00K | 288.00K | 1.40M | 3.00M | |||
| Taxes Paid | 7.80M | 19.21M | 8.77M | 11.60M | 3.70M | |||
| Other non cash items | -118.89M | 62.28M | -16.39M | 33.30M | 31.40M | |||
| OPERATING CASH FLOW | 49.36M | 97.05M | 49.58M | 137.90M | 78.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -452.00K | -1.82M | -64.25M | -17.90M | -8.80M | |||
| Other Investing Activity | -376.87M | -141.84M | 52.57M | 181.50M | 39.30M | |||
| INVESTING CASH FLOW | -377.32M | -143.66M | -11.68M | 163.60M | 30.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 459.97M | -25.00K | -76.90M | -261.00M | -164.90M | |||
| Stock Issued/Repurchased | 99.89M | 102.73M | 22.45M | 3.20M | 15.30M | |||
| Other Financing Activity | -131.64M | -5.56M | -5.50M | -18.20M | 11.90M | |||
| FINANCING CASH FLOW | 428.22M | 97.14M | -59.95M | -276.00M | -137.80M | |||
| Exchange Rate Effect | 2.36M | -1.17M | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 102.62M | 49.35M | -22.05M | 25.50M | -28.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 49.36M | 97.05M | 49.58M | 137.90M | 78.80M | |||
| Capital Expenditure | -452.00K | -1.82M | -64.25M | -17.90M | -8.80M | |||
| FREE CASH FLOW | 48.91M | 95.23M | -14.68M | 120.00M | 70.00M | |||
All data in USD